drugset / Trial / NCT05136625

Sphenopalatine Ganglion Block and Pain Management in Neurosurgery

NCT05136625

Unknown 84 enrolled University Hospital of Ferrara
RandomizedParallel-groupDouble-blindTreatment

Summary

Post craniotomy pain is defined as headache developed up to 7 days from a craniotomy, not otherwise explained. A moderate to severe pain affects from 60 to 84% of patients. Sphenopalatine ganglion block has been successfully used in patients with chronic or acute headache, facial pain and for transsphenoidal pituitary and endoscopic sinus surgeries. There are evidences that sphenopalatine ganglion block reduces vegetative responses to skull pin closure. This study aim to investigate feasibility and efficacy of sphenopalatine ganglion block in reducing pain after a neurosurgical supratentorial craniotomy.

Timeline

Start
2021-02-01
Primary completion
2024-01-31
Completion
2024-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 7.5 % Intranasal
Background Mepivacaine Other / unclassified Other

Indications

No indication recorded.